UK markets closed

Hims & Hers Health, Inc. (HIMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
12.29-0.63 (-4.88%)
At close: 04:00PM EDT
12.30 +0.01 (+0.08%)
After hours: 08:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close12.92
Open12.88
Bid12.28 x 2200
Ask12.30 x 1800
Day's range12.17 - 12.97
52-week range5.65 - 17.16
Volume6,883,094
Avg. volume6,344,574
Market cap2.775B
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)-0.01
Earnings date05 Aug 2024 - 09 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.52
  • Simply Wall St.

    Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

    Hims & Hers Health, Inc. ( NYSE:HIMS ) just released its first-quarter report and things are looking bullish. It was...

  • Yahoo Finance Video

    Oscar Health, Kenvue, Hims & Hers: Health earnings roundup

    Yahoo Finance Health Reporter Anjalee Khemlani joins Wealth! to analyze this morning's round of earnings out from top health companies, including health insurance provider Oscar Health (OSCR), consumer health product maker Kenvue (KVUE), and telehealth distributor Hims & Hers Health (HIMS). Most notably, Oscar Health reported a profitable quarter as it saw enrollment figures rise. Kenvue's stock is moving higher Tuesday morning while also announcing plans to layoff 4% of its workforce. Ahead of reporting earnings, Hims & Hers CEO Andrew Dudum has weighed in on the Israel-Palestine conflict and recent college protests on social media.l For more expert insight and the latest market action, click here to watch this full episode of Wealth! This post was written by Luke Carberry Mogan.

  • Yahoo Finance Video

    Him & Hers Health stock soars on Q1 revenue beat, Q2 guidance

    Hims & Hers Health (HIMS) shares are surging after Monday's market close, fueled by the company's first quarter earnings beat. The telehealth platform reported revenue growth of 46% year-over-year, followed by a better-than-expected second quarter outlook, boosting investor confidence in the stock. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith